BioMarin Pharmaceutical Inc.

Our Purpose

At BioMarin, we translate the promise of genetic discovery into medicines that make a profound impact on the life of each patient.

Since our founding in 1997, we’ve developed a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, we seek to unleash the full potential of genetic science by pursuing category-defining medicines that offer new possibilities for people living with genetically defined conditions around the world.

As we have looked to expand our impact, our approach to cutting-edge science has remained the same. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science.

770 Lindaro Street
San Rafael, CA 94901

105 Digital Drive
Novato, CA 94949

Tel: (415) 506-6700

Visit website

NEWS

Drug Development

Survey Says: Top 5 Trends in the Life Sciences Industry

Recently, BioSpace posted a question on its website, under the heading, “We Want to Hear from You! Top Life Sciences Trends.” Let’s take a look at the five trends survey participants mentioned.

September 25, 2018

5 min read

Mark Terry

Deals

Amicus Therapeutics Buys Celenex for $100 Million up Front

Amicus Therapeutics, headquartered in Cranbury, New Jersey, inked a definitive agreement for 10 gene therapy programs licensed from Nationwide Children’s Hospital through the acquisition of Celenex.

September 20, 2018

3 min read

Mark Terry

Business

Movers and Shakers for Sept. 10

Let’s take a look at who made a splash in the pharma and biotech world the past week.

September 7, 2018

5 min read

Alex Keown

Pictured: Office building science collage

Job Trends

The Top 12 Biopharma Companies Hiring Now

Despite the changing landscape in biopharma, many companies are still recruiting. If you’re looking to make a career change, here are 12 biopharma companies hiring on BioSpace now.

September 5, 2018

1 min read

Editorial Staff

BioMidwest

Express Scripts Eyes Expanding Coverage of Million Dollar-Plus Gene Therapies

Express Scripts is already known for its role of bringing prescriptions to the doors of consumers. Now the company is moving into a new area of providing medicines—expensive gene therapies.

August 15, 2018

2 min read

Alex Keown

Drug Development

Gene Therapy Shows Promise for Ending Hemophilia, With Some Long-Term Concerns

Gene therapy has been a dream for many researchers for decades—inserting a healthier gene into patients’ cells to replace defective genes and curing diseases. One disease that would seem to be a good target for gene therapy is hemophilia.

August 14, 2018

3 min read

Mark Terry

Pharm Country

Top 10 Stories of the First Half of 2018

It’s hard to believe 2018 is half over. There have been plenty of interesting and important stories in the biopharma space this year. Here’s a look at our top 10 stories so far, counting down from 10 to the number one story.

July 3, 2018

5 min read

Mark Terry

Drug Development

A Look at Hemophilia Drug Prices and the Market

Miracles, it seems, have a high price tag. At least, if those miracles are miracle drugs. There’s no doubt that trends in gene therapy and immuno-oncology are producing drugs that are as close to miraculous as we’re likely to get, doing a great job, generally, in beating back diseases that to this point were untreatable or didn’t respond well to other therapies.

July 2, 2018

4 min read

Mark Terry

Manhattan, New York USA - July 9, 2011: Pfizer letter sign on the building's Headquarters. Pfizer's is the largest pharmaceutical company in the world.

Business

Pfizer Pays BioMarin Pharma $20 Million Milestone

BioMarin Pharmaceutical received $20 million in milestone payments from Pfizer after the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) approved its applications for talazoparib.

June 7, 2018

3 min read

Mark Terry

JOBS